Clarrio.ai reads your physique alerts to avoid wasting your life

Dependable well being information stays scarce in lots of African international locations, leaving medical doctors to make remedy selections with solely fragments of the total image. A 2021 World Well being Organisation (WHO) report discovered that almost two-thirds of nations in its African area lacked the capability to precisely document births and deaths, whereas information on non-communicable ailments was even thinner. 

For thousands and thousands of individuals with continual ailments, this data hole undermines care, analysis, drug manufacturing, and well being system planning. 

Clarrio.ai, a predictive analytics platform, recognised this drawback and is utilizing superior synthetic intelligence to rework an individual’s physiological, behavioural, and environmental alerts into predictive insights.

Clarrio was initially referred to as Knowlepsy when it launched in 2023 and was devoted to addressing epilepsy administration. CEO and Co-founder, Firas Rhaiem, whose ‘s sister who was epileptic couldn’t obtain proactive remedy due to lacking well being data, together with frequency of seizures and different environmental information. Rhaeim started constructing a device to combination and interpret her data. It remodeled his sister’s care, shifting her from weekly seizures to going years with out one. 

After Rhaiem and his workforce started to look into the issue of lacking well being information, they recognised that not solely epileptic sufferers confronted this problem. “We noticed that nobody had information not just for epilepsy however for all continual ailments. When you depart the hospital, you’re disconnected,” Rhaiem stated. 

Knowlepsy rebranded from a distinct segment epilepsy platform to Clarrio, a device-agnostic information aggregation platform for continual ailments.

The way it works

KnowRisk is Clarrio’s core utility suite. For sufferers with continual ailments, it’s an app linked to their wearable gadgets, like a smartwatch, logging environmental information and actions like sleep, stress, temper, menstrual cycle, and Coronary heart Fee Variability. The platform makes use of a Convolutional Neural Community (CNN)—a pc system designed to extract options from grid-like matrix datasets—to transform the real-time information and historic information into patterns for sample recognition. 

To extract the info factors, KnowRisk makes use of Massive Language Fashions (LLMs). It additionally makes use of Lengthy Brief-Time period Reminiscence (LSTM)—a pc community that remembers prior data and makes use of it for processing the present enter—for predictive evaluation. This course of permits the system to assist sufferers determine and keep away from private triggers that would escalate their situation. The platform is interoperable and works throughout 300 gadgets, together with Huawei, Apple, Xiaomi, Fitbit, and gadgets provided by Clarrio.

For hospitals, pharma corporations, and different medical entities, KnowRisk is a Software program as a Service (SaaS) dashboard that unifies incoming affected person information with medical data and generates early AI-driven danger alerts. It may be deployed in superior and resource-limited hospital environments, because it requires solely primary web entry. The platform shouldn’t be restricted to a particular illness—it at present covers epilepsy and migraine and is engaged on bronchial asthma instances and heart problems.

Underneath the hood

Clarrio’s enterprise mannequin is strictly business-to-business (B2B), focused at well being programs, pharmaceutical corporations, and insurers. Sufferers and medical doctors use the platform without spending a dime. Prices are charged yearly to institutional gamers from $942 to $1,178 per affected person, or they will enter into bigger enterprise contracts.

The startup identifies its main rivals as Flatiron Well being, Verily, and IQVIA—world gamers largely targeted on oncology or working with remoted, siloed information. It believes its deal with continual ailments, its means to seize information exterior hospitals, and a proprietary dataset derived from real-world experiences, are main promoting factors.

Clarrio, which is utilized by over 500 sufferers, is lively in Tunisia, Qatar, and South Africa via its partnership with hospitals, together with Sidra Medication and Hamad Medical Company (HMC) in Qatar and Netcare Hospitals in Johannesburg. It additionally companions with Microsoft, which lists, sells, and helps Clarrio via its market. 

Clarrio is venture-backed and claims to have raised over $1 million in fairness from over 25 enterprise angels and senior executives from Microsoft and Google. It claims to have achieved a 78.9% accuracy in detecting seizure triggers and a 30% drop in emergency visits. 

It plans to develop from Africa and Qatar to the US market in 2026, broadening its illness protection to most cancers and autoimmune ailments. The corporate goals to assist the subsequent wave of healthtech startups via anonymised information sharing.

“I’m not promoting prediction,” Rhaiem provides. “I’m promoting entry to well being information. When you have entry to information, all the pieces will change into extra personalised. As soon as personalised, the most important winner is your entire healthcare system and the sufferers.”

Mark your calendars! Moonshot by TechCabal is again in Lagos on October 15–16! Meet and be taught from Africa’s high founders, creatives & tech leaders for two days of keynotes, mixers & future-forward concepts. Get your tickets now: moonshot.techcabal.com